Search Results

At McGill, his laboratory has two main axes of research: 1) Studying interindividual vulnerability to

GPCR University ecosystem — maintained, updated, and accessible to learners in the long term. Course details – title, format (short talk / mini-course / series), audience, main objectives, expected

NMDA receptor is a subtype of glutamate neurotransmitter receptor that regulates the formation and maintenance

As a developer, and more recently the lead developer of GPCRdb my day-to-day work centers around the maintenance

structure-based models and enhanced sampling techniques, as well as their application to biomolecular systems, mainly

Proprietary no-wash technologies help reduce hands-on time while maintaining exceptional data quality—so

lymphatic endothelial cells (LECs), a cellular model with unique junction arrangements where aGPCRs are mainly

Full Agenda Session VI AGPCRs shaping the nervous system ADGRCs in glutamatergic synapse formation, maintenance modulation of dopaminergic neurotransmission Nicole Perry-Hauser ADGRCs in glutamatergic synapse formation, maintenance Celsr1-3) are components of the conserved planar cell polarity (PCP) pathway, which establishes and maintains will also present ongoing work on the signaling mechanisms of how ADGRCs regulate synapse formation, maintenance

Our first main research aspect is the identification of endogenous ligand of GPCRs. Our second main research aspect is dissecting the molecular mechanism underlying sensation of force, Our third main research aspect is working mechanism of GPCR. Our fourth main research aspect is ligand coding mechanisms and structural aided drug discovery of GPCR

lymphatic endothelial cells (LECs), a cellular model with unique junction arrangements where aGPCRs are mainly

BAI1-3 are highly expressed in the brain, where they participate in synaptogenesis and synapse maintenance

— not only on tactical execution, but on pressure-testing hypotheses, challenging assumptions, and maintaining

As a developer, and more recently the lead developer of GPCRdb my day-to-day work centers around the maintenance

His main research group centers on the function, structure, and regulation of G protein-coupled receptors

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

This work contributes to a better understanding of how the kidney helps maintain homeostasis in humans

In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia

.” – Ilana Kotliar The team developed two main assets: A web interface to visualize antibody validations physician-scientist and Rockefeller University professor dedicated to drug discovery and chemical biology research, mainly

researchers and biotech companies find the right opportunities to grow together Community Infrastructure: maintaining

Atypical Chemokine Receptor 3 (ACKR3), a receptor which does not couple to G protein and has been shown to maintain

David has over 20+ years of experience working in a drug discovery environment mainly in a specialist

My main topics were protein biochemistry, Drosophila husbandry, and genetics. Since then, I have broadened my horizons with many more techniques in vivo and in vitro, with a main

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

His current work is mainly focused on screening and assay development to bridge the gap between in vitro

The main focus of his lab’s research is on the mechanisms underlying biased agonism at chemokine receptors

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

“The main challenge was: how do we get a face for these proteins when we don’t have ligands?”

pharmacologist with over 20 years of drug discovery research in the pharmaceutical industry, where he works mainly

In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia